Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I0ZO
|
||||
Former ID |
DIB015781
|
||||
Drug Name |
Anti-CD45 mabs
|
||||
Synonyms |
AHCD45 therapy, Baylor College; YTH-24; YTH-24/54; YTH-25.4; YTH-54.12; Anti-CD45 mAbs (stem cell transplantation/cancer); Anti-CD45 mAbs (stem cell transplantation/cancer), Baylor College
|
||||
Drug Type |
Antibody
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Phase 1 | [521588] | ||
Company |
Baylor College of Medicine
|
||||
Target and Pathway | |||||
Target(s) | Leukocyte common antigen | Target Info | [528286] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
Pathway Interaction Database | BCR signaling pathway | ||||
TCR signaling in naï | |||||
TCR signaling in naï | |||||
CXCR4-mediated signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.